Li Lin
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Wnt/β-catenin signaling in development and cancer
- Cancer-related gene regulation
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- Circular RNAs in diseases 4
- Heat shock proteins research 3
- Cancer-related gene regulation 3
- Surgery 7
- Cardiovascular, Neuropeptides, and Oxidative Stress Research 4
- Co-authors
- Dianqing Wu (1 shared paper)Bo Liu (1 shared paper)Gist H. Farr (1 shared paper)Christopher Flynn (1 shared paper)Shinji Takada (1 shared paper)Jiyong Wang (1 shared paper)Junhao Mao (1 shared paper)David Kimelman (1 shared paper)
- Journals
- The FASEB Journal (3 papers)Cardiovascular Research (2 papers)Science China Life Sciences (2 papers)Chemotherapy (2 papers)Physiological Genomics (2 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Li Lin
45 papers receiving 1.9k citations
Li Lin's Hit Papers
Peers
Comparison fields: 5 of 102
- Cancer Research 316
- Molecular Biology 1.2k
- Nephrology 77
- Endocrine and Autonomic Systems 65
- Cell Biology 146
Countries citing papers authored by Li Lin
This map shows the geographic impact of Li Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Lin more than expected).
Fields of papers citing papers by Li Lin
This network shows the impact of papers produced by Li Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Lin. The network helps show where Li Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Low-Density Lipoprotein Receptor-Related Protein-5 Binds to Axin and Regulates the Canonical Wnt Signaling Pathway Hit paper breakdown → | 2001 | 708 |
| 2 | 2020 | 162 | |
| 3 | 2011 | 136 | |
| 4 | 2010 | 119 | |
| 5 | 2013 | 105 | |
| 6 | 2008 | 52 | |
| 7 | 2008 | 50 | |
| 8 | 2015 | 41 | |
| 9 | 2016 | 39 | |
| 10 | 2007 | 35 | |
| 11 | 2017 | 35 | |
| 12 | 2011 | 31 | |
| 13 | 2008 | 27 | |
| 14 | 2014 | 27 | |
| 15 | 2015 | 26 | |
| 16 | 1988 | 25 | |
| 17 | 2007 | 24 | |
| 18 | 1990 | 24 | |
| 19 | 2019 | 23 | |
| 20 | 2016 | 23 |
About Li Lin
Li Lin is a scholar working on Molecular Biology, Surgery, Cardiology and Cardiovascular Medicine, Physiology and Cancer Research, having authored 48 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (5 papers), Nitric Oxide and Endothelin Effects (4 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (4 papers), Cancer-related molecular mechanisms research (4 papers), Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (4 papers), Heat shock proteins research (3 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Cancer Research (316 citations), Molecular Biology (1.2k citations), Nephrology (77 citations), Endocrine and Autonomic Systems (65 citations) and Cell Biology (146 citations). Li Lin has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Dianqing Wu, Bo Liu, Gist H. Farr, Christopher Flynn, Shinji Takada, Jiyong Wang, Junhao Mao, David Kimelman, Huidong Yuan and Weijun Pan. Their work appears in journals such as The FASEB Journal, Cardiovascular Research, Science China Life Sciences, Chemotherapy and Physiological Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.